Clinical trial
Is Tranexamic Acid Effective in Limiting Transfusion After Hip Replacement for Femoral Neck Fracture: A Randomized Controlled Trial
NCT01714336 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Is Tranexamic Acid Effective in Limiting Transfusion After Hip Replacement for Femoral Neck Fracture: A Randomized Controlled Trial
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- October 31, 2015
- Enrollment
- 138 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hip fracture